Close

Pluristem Therapeutics (PSTI) Announces Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. MSFT


Go back to Pluristem Therapeutics (PSTI) Announces Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions

Pluristem Enters into Collaboration with NASA to Study PLX Therapeutic Benefits in Space Missions

February 20, 2019 7:31 AM EST

HAIFA, Israel, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced a collaboration between the company and NASAs Ames Research Center to evaluate the potential of Pluristems PLX cell therapies in preventing and... More